普萘洛尔联合奥曲肽治疗肝硬化上消化道出血的临床疗效以及对患者生活质量的影响

朱建华; 计钰亮; 杨君寅

doi:10.3969/j.issn.1671-038X.2017.05.04

普萘洛尔联合奥曲肽治疗肝硬化上消化道出血的临床疗效以及对患者生活质量的影响

- 武警浙江总队嘉兴医院消化内科, 浙江嘉兴 314000

详细信息

作者简介:
朱建华,男,大学本科,主治医师,研究方向:消化疾病的治疗

通讯作者: 朱建华,E-mail:13957384192@139.com

中图分类号: R575.2

收稿日期: 2016-12-03

The effect of propranolol combined with octreotide on clinical efficacy and quality of life in cirrhosis patients with upper digestive tract hemorrhage

- Department of Digestive Medicine, Jiaxing Hospital of Zhejiang Armed Police Corps, Zhejiang 314000, China

More Information

Corresponding author: ZHU Jian-hua, E-mail: 13957384192@139.com

Received Date: 03 December 2016

摘要

摘要: [目的]观察普萘洛尔联合奥曲肽治疗肝硬化上消化道出血的临床疗效以及其对患者生活质量的影响。[方法]选取我院2014年3月~2016年9月住院治疗的肝硬化肝硬化上消化道出血患者128例，使用随机数字法分为对照组和观察组，每组64例。比较2组的止血时间和输血量。彩色多普勒超声显像仪测定门静脉内径和门静脉血流量，生活质量（QOL）量表评价患者治疗前后的生活质量。比较2组临床疗效和不良反应发生率。[结果]观察组平均止血时间为（21.62±5.17） h，显著短于对照组的（32.87±7.21） h （P<0.05）。观察组平均输血量为（1.62±0.45） U，显著少于对照组的（2.52±0.64） U （P<0.05）。治疗前2组门静脉内径和门静脉血流量无显著性差异无统计学意义（P>0.05），治疗后观察组门静脉内径和门静脉血流量均显著低于对照组（P<0.05）。治疗前2组躯体功能、角色功能、认知功能、情绪功能、社会功能、整体功能生存质量评分差异无统计学意义（P>0.05），治疗后观察组上述生存质量指标评分均显著高于对照组（P<0.05）。观察组的有效率为92.2%（59/64），显著高于对照组的73.4%（47/64）（P<0.05）。观察组不良反应发生率为9.4%（6/64），对照组不良反应发生率为7.8%（5/64），2组不良反应差异无统计学意义（P>0.05）。[结论]普萘洛尔联合奥曲肽治疗肝硬化上消化道出血，使血流动力学指得到显著改善，提高临床疗效并改善患者的生活质量，临床使用安全。
- 普萘洛尔 /
- 奥曲肽 /
- 肝硬化 /
- 上消化道出血 /
- 生活质量
Abstract: [Objective] To observe the effect of propranolol combined with octreotide on clinical efficacy and quality of life in cirrhosis patients with upper digestive tract hemorrhage.[Methods] 128 cirrhosis patients with upper digestive tract hemorrhage were sellected in this study.The patients were divided into:control group(n=64) and observation group(n=64).The hemostatic time and blood transfusion valume were compared between the two groups.The diameter of portal vein and portal vein blood flow were measured by color Doppler flow imaging.Quality of life(QOL) scale was used to evaluate the quality of life of patients before and after treatment.The clinical effect and adverse reaction rate were compared between the two groups.[Results] The average hemostasis time in observation group was 21.62±5.17 h, which was significantly shorter than that of 32.87±7.21 h in control group(P<0.05).The average blood transfusion valume in observation group was 1.62±0.45 U, which was significantly less than that of 2.52±0.64 U in control group(P<0.05).There was no significant difference in the diameter of portal vein and portal vein blood flow between the two groups before treatment.After treatment, they were both lower in observation group than that in control group(P<0.05).There was no significant difference of physical function, role function, cognitive function, emotional function, social function, global function scores between the two groups before treatment.After treatment, they were all higher in observation group than that in control group(P<0.05).The clinical effect was 92.2%(59/64) in observation group, which was higher than that of 73.4%(47/64) in control group.The rate of adverse reaction was 9.4%(6/64) in observation group and 7.8%(5/64) in control group.There was no significant difference between the two groups(P>0.05).[Conclusion] Propranolol combined with octreotide improved hemodynamics, quality of life, and clinical efficacy in treatment of liver cirrhosis with upper gastrointestinal bleeding, with clinical use of safety.
- propranolol /
- octreotide /
- cirrhosis /
- upper gastrointestinal bleeding /
- quality of life

HTML全文

参考文献(10)

[1]	Poordad F F.Presentation and complications associated with cirrhosis of the liver[J].Curr Med Res Opin, 2015, 31:925-937.
[2]	Cerini F, Gonzalez J M, Torres F, et al.Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis, A retrospective multicenter study[J].Hepatology, 2015, 62:575-583.
[3]	王建荣, 陆文霞, 夏玉敬, 等.门脉高压药物治疗进展[J].世界临床药物, 2016, 37(1):61-66.
[4]	王彦先.用普萘洛尔治疗代偿性肝硬化门静脉高压症的效果分析[J].当代医药论丛, 2016, 14(3):81-82.
[5]	宋奇峰, 周建波, 桑建忠, 等.奥曲肽联合奥美拉唑治疗肝硬化上消化道出血的疗效观察[J].中国生化药物杂志, 2016, 36(8):127-129.
[6]	中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J].临床肝胆病杂志, 2016, 32(2):203-219.
[7]	徐灵通, 霍鑫龙.联合给药在消化道出血中的疗效观察及对生活质量的影响[J].世界华人消化杂志, 2016, 24(30):4223-4226.
[8]	Mayorga CA, Rockey DC.Clinical utility of a standardized electronic order set for the management of acute upper gastrointestinal hemorrhage in patients with cirrhosis[J].Clin Gastroenterol Hepatol, 2013, 11:1342-1348.
[9]	杨辉, 周筱燕, 周岩芬, 等.奥曲肽联合隔下逐瘀汤治疗肝硬化上消化道出血患者临床疗效和血流动力学的变化[J].实用肝脏病杂志, 2016, 19(4):459-462.
[10]	贺永锋, 杨小翠, 张健涛, 等.奥曲肽联合普萘洛尔治疗肝硬化食管胃底静脉曲张破裂后出血的临床分析[J].药物评价研究, 2016, 39(2):274-277.